Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Victor Knopov

Premium

Regulus Therapeutics has named Victor Knopov its vice president of pharmaceutical development.

He most recently served as director of chemistry manufacturing control at Nitto Denko Technical. Before that, Knopov was COO at Diversified Bio-Medics and has previously worked as a consultant for Marina Biotech.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.